WeChat Mini Program
Old Version Features

Abstract C133: Effective Targeting of KRAS-driven Tumors by the First-in-class, Orally Bioavailable SOS1::KRAS Inhibitor BI-3406

Marco H. Hofmann,Michael Gmachl,Jurgen Ramharter,Fabio Savarese,Michael P. Sanderson,Daniel Gerlach,Francesca Trapani,Dana-Adriana Botesteanu,Dirk Kessler,Peter Ettmayer,Heribert Arnhof,Thomas Gerstberger,Renate Schnitzer,Christiane Kofink,Heinz Stadtmueller,Tobias Wunberg,Jonathan C. O'Connell,Rachel L. Mendes,David Richard, Adrian S. Saldanha,Juergen Moll,Mark Pearson,Darryl B. McConnell,Norbert Kraut

MOLECULAR CANCER THERAPEUTICS（2019）

Cited 2|Views43
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined